Company Avricore Health Inc Toronto S.E.
Equities
APH
CA92143R2046
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
HealthTab - Point of Care
100.0
%
| 2 | 100.0 % | 3 | 100.0 % | +97.08% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 2 | 100.0 % | 3 | 100.0 % | +97.08% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hector Bremner
CEO | Chief Executive Officer | - | 18-12-31 |
Kiki Smith
DFI | Director of Finance/CFO | - | 19-08-05 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Hall
CHM | Chairman | 71 | 16-01-19 |
Robert Sindelar
BRD | Director/Board Member | 71 | 18-03-26 |
Christine Hrudka
BRD | Director/Board Member | - | 23-06-20 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-07 |
Alan Arnstein
BRD | Director/Board Member | 56 | 17-04-19 |
Hector Bremner
CEO | Chief Executive Officer | - | 18-12-31 |
Thomas Teahen
BRD | Director/Board Member | - | 23-06-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 99,869,664 | 90,172,435 ( 90.29 %) | 0 | 90.29 % |
Company contact information
Avricore Health, Inc.
789 West Pender Street Suite 1120
V6C 1H2, Vancouver
+
http://www.avricorehealth.com![address Avricore Health Inc(APH)](https://cdn.zonebourse.com/static/address/1409027.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |